Patents by Inventor Robert B. Steffen

Robert B. Steffen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Comfortable ophthalmic device and methods of its production
    Patent number: 12461280
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices by treating a polymerized ophthalmic lens with a polymeric wetting agent, wherein the ophthalmic lens does not comprise said polymeric wetting agent prior to its polymerization.
    Type: Grant
    Filed: October 18, 2023
    Date of Patent: November 4, 2025
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • COMFORTABLE OPHTHALMIC DEVICE AND METHODS OF ITS PRODUCTION
    Publication number: 20240142666
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.
    Type: Application
    Filed: October 18, 2023
    Publication date: May 2, 2024
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • Comfortable ophthalmic device and methods of its production
    Patent number: 11953651
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.
    Type: Grant
    Filed: August 24, 2021
    Date of Patent: April 9, 2024
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • BIOMEDICAL DEVICES CONTAINING INTERNAL WETTING AGENTS
    Publication number: 20220268966
    Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
    Type: Application
    Filed: May 13, 2022
    Publication date: August 25, 2022
    Inventors: Kevin P. McCabe, Frank F. Molock, JR., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
  • COMFORTABLE OPHTHALMIC DEVICE AND METHODS OF ITS PRODUCTION
    Publication number: 20220206187
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.
    Type: Application
    Filed: August 24, 2021
    Publication date: June 30, 2022
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • Biomedical devices containing internal wetting agents
    Patent number: 11360241
    Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
    Type: Grant
    Filed: January 28, 2021
    Date of Patent: June 14, 2022
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Frank F. Molock, Jr., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
  • Comfortable ophthalmic device and methods of its production
    Patent number: 11150383
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices by treating unhydrated, polymerized ophthalmic lens with a polymeric wetting agent, wherein the ophthalmic lens formulation does not comprise said wetting agent prior to its polymerization.
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: October 19, 2021
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • BIOMEDICAL DEVICES CONTAINING INTERNAL WETTING AGENTS
    Publication number: 20210149084
    Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
    Type: Application
    Filed: January 28, 2021
    Publication date: May 20, 2021
    Inventors: Kevin P. McCabe, Frank F. Molock, JR., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
  • Biomedical devices containing internal wetting agents
    Patent number: 10935696
    Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: March 2, 2021
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Frank F. Molock, Jr., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
  • BIOMEDICAL DEVICES CONTAINING INTERNAL WETTING AGENTS
    Publication number: 20200233118
    Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
    Type: Application
    Filed: April 3, 2020
    Publication date: July 23, 2020
    Inventors: Kevin P. McCabe, Frank F. Molock, JR., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
  • Ophthalmic devices
    Patent number: 10668676
    Abstract: An ophthalmic device is disclosed that is a polymerization product of a monomeric mixture comprising: (a) a major amount of one or more non-silicone-containing hydrophilic monomers; (b) a crosslinking agent mixture comprising (i) one or more first crosslinking agents containing at least two ethylenically unsaturated reactive end groups, wherein the at least two ethylenically unsaturated reactive end groups are (meth)acrylate-containing reactive end groups and (ii) one or more second crosslinking agents containing at least two ethylenically unsaturated reactive end groups wherein at least one of the ethylenically unsaturated reactive end groups is a non-(meth)acrylate reactive end group, and (c) one or more hydrophilic polymers or copolymers comprising one or more hydrophilic units and a thio carbonyl thio fragment of a reversible addition fragmentation chain transfer (“RAFT”) agent wherein the ophthalmic device has an equilibrium water content of at least about 45 weight percent.
    Type: Grant
    Filed: August 10, 2018
    Date of Patent: June 2, 2020
    Assignee: Bausch & Lomb Incorporated
    Inventors: Ivan M. Nuñez, Lynn Coullard, Daniel J. Hook, Robert B. Steffen, Daniel M. Ammon, Jennifer M. Hunt, Analuz Mark
  • Biomedical devices containing internal wetting agents
    Patent number: 10641926
    Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
    Type: Grant
    Filed: February 13, 2019
    Date of Patent: May 5, 2020
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Frank F. Molock, Jr., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
  • OPHTHALMIC DEVICES
    Publication number: 20200047437
    Abstract: An ophthalmic device is disclosed that is a polymerization product of a monomeric mixture comprising: (a) a major amount of one or more non-silicone-containing hydrophilic monomers; (b) a crosslinking agent mixture comprising (i) one or more first crosslinking agents containing at least two ethylenically unsaturated reactive end groups, wherein the at least two ethylenically unsaturated reactive end groups are (meth)acrylate-containing reactive end groups and (ii) one or more second crosslinking agents containing at least two ethylenically unsaturated reactive end groups wherein at least one of the ethylenically unsaturated reactive end groups is a non-(meth)acrylate reactive end group, and (c) one or more hydrophilic polymers or copolymers comprising one or more hydrophilic units and a thio carbonyl thio fragment of a reversible addition fragmentation chain transfer (“RAFT”) agent wherein the ophthalmic device has an equilibrium water content of at least about 45 weight percent.
    Type: Application
    Filed: August 10, 2018
    Publication date: February 13, 2020
    Inventors: Ivan M. Nuñez, Lynn Coullard, Daniel J. Hook, Robert B. Steffen, Daniel M. Ammon, Jennifer M. Hunt, Analuz Mark
  • COMFORTABLE OPHTHALMIC DEVICE AND METHODS OF ITS PRODUCTION
    Publication number: 20190317246
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.
    Type: Application
    Filed: March 6, 2019
    Publication date: October 17, 2019
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • BIOMEDICAL DEVICES CONTAINING INTERNAL WETTING AGENTS
    Publication number: 20190187332
    Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
    Type: Application
    Filed: February 13, 2019
    Publication date: June 20, 2019
    Inventors: Kevin P. McCabe, Frank F. Molock, JR., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
  • Comfortable ophthalmic device and methods of its production
    Patent number: 10267952
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices by treating unhydrated, polymerized ophthalmic lens with a polymeric wetting agent, wherein the ophthalmic lens formulation does not comprise said wetting agent prior to its polymerization.
    Type: Grant
    Filed: June 7, 2016
    Date of Patent: April 23, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • Biomedical devices containing internal wetting agents
    Patent number: 10254443
    Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
    Type: Grant
    Filed: March 12, 2018
    Date of Patent: April 9, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Frank F. Molock, Jr., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
  • BIOMEDICAL DEVICES CONTAINING INTERNAL WETTING AGENTS
    Publication number: 20180203161
    Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
    Type: Application
    Filed: March 12, 2018
    Publication date: July 19, 2018
    Inventors: Kevin P. McCabe, Frank F. Molock, JR., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
  • Biomedical devices containing internal wetting agents
    Patent number: 9958577
    Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
    Type: Grant
    Filed: June 25, 2015
    Date of Patent: May 1, 2018
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Frank F. Molock, Jr., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
  • Contact lenses
    Patent number: 9507172
    Abstract: The invention provides silicone hydrogel contact lenses that exhibit reduced back surface debris and reduced incidence of superior epithelial accurate lesions.
    Type: Grant
    Filed: May 1, 2014
    Date of Patent: November 29, 2016
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Robert B. Steffen, David C. Turner, Douglas G. Vanderlaan